SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH – Get Free Report)’s share price crossed above its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $65.67 and traded as high as $67.45. SPDR S&P Pharmaceuticals ETF shares last traded at $67.37, with a volume of 639,639 shares traded.
SPDR S&P Pharmaceuticals ETF Price Performance
The stock has a 50 day simple moving average of $65.59 and a two-hundred day simple moving average of $62.08. The company has a market cap of $512.71 million, a price-to-earnings ratio of 14.28 and a beta of 0.62.
Institutional Investors Weigh In On SPDR S&P Pharmaceuticals ETF
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Bank of America Corp DE lifted its stake in SPDR S&P Pharmaceuticals ETF by 128.0% during the 1st quarter. Bank of America Corp DE now owns 811,939 shares of the company’s stock worth $43,918,000 after acquiring an additional 455,802 shares in the last quarter. Parkway Wealth Management Group LLC purchased a new position in shares of SPDR S&P Pharmaceuticals ETF in the 3rd quarter valued at about $24,754,000. First Citizens Bank & Trust Co. acquired a new stake in SPDR S&P Pharmaceuticals ETF during the third quarter worth approximately $11,083,000. Private Advisor Group LLC purchased a new stake in SPDR S&P Pharmaceuticals ETF in the third quarter valued at $6,685,000. Finally, Integrated Wealth Concepts LLC purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF in the 2nd quarter valued at about $3,350,000.
SPDR S&P Pharmaceuticals ETF Company Profile
SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Featured Articles
- Five stocks we like better than SPDR S&P Pharmaceuticals ETF
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for SPDR S&P Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.
